-- Sichuan Hebang Biotechnology (SHA:603077) swung to a net loss attributable to shareholders of 536.4 million yuan, or 0.0522 yuan per share, in 2025, according to a Shanghai bourse filing on Tuesday.
The attributable profit a year earlier was 31.5 million yuan, or 0.0037 yuan per share.
Operating revenue dropped 16% to 7.19 billion yuan from 8.58 billion yuan in the previous year.
The Chinese biotechnology company's shares fell 7% during the afternoon trade.